25 Jan 2021Ended

Launch of ICON and STUDIUS New Products for an Integrated Cell Line Development Workflow


Estimated Turnout

upto 100
Based on previous editions


Jan 2021


Not Available
Claim event to edit details

From the original notion of monoclonal antibodies as “magic bullets” right through to the latest generation of COVID-19 vaccines, stem cell .. Read more therapies and exosomes, cell line development is experiencing a rapid expansion in both scope and output of novel biotherapeutics. Clonality, and the gathering of quality evidence, has been central to cell line development for the last decade, and with it, driving the rise of high-caliber seeding and imaging technologies. Learn about how these two new products integrate with existing Solentim platforms to build a new data-driven workflow for the development of modern cell-based therapies. Participants will be hearing from Solentim’s R&D and biology groups alongside cell line development experts in this first insight into Solentim’s new products. Duncan Borthwick has a PhD from the University of Edinburgh and University of North Carolina, Chapel Hill. Since hanging up his lab coat 20+ years ago, Duncan has worked in the development of novel instrumentation and products. He heads the Product Management group at Solentim, working closely with the R&D, biology and commercial teams to define the next set of products to support the cell therapy community.

  • Share your Experience
  • Organizer
Logo Follow Company


Canada352 Total Events / 50 Upcoming Events

More Events From The Organizer